On-demand webinar thumbnail with colourful light trails

Strengthening Causal Inference with Sensitivity Analyses: Using the Bayesian Parametric G-Formula

2 minute read

Published: February 19th, 2025

Understanding causal relationships in real-world data is challenging, particularly in observational studies, where confounding can introduce bias. If confounding is not properly accounted for, treatment effect estimates may be misleading, impacting decision-making.

Therefore, correctly modelling confounding is essential for valid causal inferences. Two popular approaches to achieve this are inverse probability of treatment weighting (IPTW) and the parametric g-formula. Both methods assume confounding has been adequately modelled. However, what if it is not?

Historically, this is listed as a limitation. In recent years, sensitivity analyses have become increasingly popular to better understand this assumption. This webinar will focus on using the Bayesian parametric g-formula as a sensitivity analysis for measured confounding. Prior information about confounders can be incorporated into the model. This allows for a better understanding of the range of the plausible effects. Various scenarios can also be considered including if the confounder is a weak confounder or strong confounder.

This approach offers a practical solution for researchers to ensure the validity of findings.

Learning Points:

  • How Bayesian methods improve sensitivity analyses
  • Incorporating prior knowledge about confounding
  • Practical applications for real-world data research

Watch this webinar recording and explore how the Bayesian Parametric G-Formula can be used as a sensitivity analysis tool to strengthen causal inference and improve the validity of findings.

Complete the form below to access the recording and slides.

Related articles

Smarter Confidence Intervals in Multicenter Trials: The BSVI Advantage

Smarter Confidence Intervals in Multicenter Trials: The BSVI Advantage

October 12th, 2026 2 minute read

Confidence intervals are an important component of clinical trial reporting, supporting the accurate and reliable int...

Regulatory Expectations: Bayesian Guidance from the FDA, CDE, and EMA

Regulatory Expectations: Bayesian Guidance from the FDA, CDE, and EMA

September 28th, 2026 2 minute read

Bayesian methods are increasingly being considered to support dose optimization, extrapolation, and adaptive designs ...

AI for Clinical Research Series – Prediction

AI for Clinical Research Series – Prediction

June 26th, 2026 1 minute read

Augmenting Clinical Trials with Synthetic or Simulated Patients, Projecting Long-Term Benefit-Risk, and Developing Re...